Case Presentation:
A 36 year‐old woman with a history of acute liver failure secondary to autoimmune hepatitis, chronic diarrhea as well as cutaneous lichen planus presented with two months of severe dysdynophagia and failure to thrive. On physical exam, the patient was cachectic and had hyperpigmented, hyperkeratotic plaques on bilateral extremities and trunk. She was also noted to have white plaques and erosions around the mucosal membranes of her mouth and vagina. Upper endoscopy showed severe erosive esophagitis consistent with lichen planus. Subsequent CT scan of her chest revealed a large anterior mediastinal mass that was resected and determined to be a malignant thymoma. Given the patient’s constellation of symptoms, she was diagnosed with a rare disorder called thymoma‐associated multiorgan autoimmunity (TAMA).
Discussion:
Patients with paraneoplastic disorders can present with widely variable clinical pictures, creating a diagnostic conundrum for for the hospitalist. Thymomas are associated with several paraneoplastic disorders, most frequently myathenia gravis. More recently, however, a rare but serious autoimmune paraneoplastic syndrome has been characterized: thymoma‐associated multiorgan autoimmunity (TAMA).
TAMA is defined as a disease of the skin, liver, or intestine that on hisopathology resembles graft‐versus host disease (GVHD) but is seen in the setting of a malignant thymoma and accompanied by gastrointestinal manifestations. The pathophysiology of TAMA is not completely understood. It is speculated that self‐reacting T‐lymphocytes that would normally be deleted in thymus during maturation spread to the periphery and act similarly to grafted lymphocytes from an unmatched bone marrow transplant.
In regards to treatment, complete resection appears to confer the best survival outcome. Unfortunately, most patients treated with a combination of chemotherapy (for unresectable tumors), immunomodulators, and systemic or topical corticosteroids died within 12 months of presentation of their GVHD‐like skin eruption. There have been less than a dozen case reports since 1997 outlining thymoma‐associated GVHD‐like skin lesions. Patients with TAMA and skin manifestations have an extremely poor prognosis and are highly susceptible to infection. Of the 10 patients reported, at least 7 died of serious infections, possibly secondary to breakdown of the protective skin‐barrier as well as immunosuppresive therapy.
Conclusions:
TAMA is a difficult and likely under‐recognized diagnosis that should stay on the hospitalist’s radar when the appropriate constellation of symptoms arises.